Drug maker Cipla has written to National Pharmaceutical Pricing Authority (NPPA), the drug price r..
Drug maker Cipla has written to National Pharmaceutical Pricing Authority (NPPA), the drug price regulator to allow price hike of [...]
The Great Harlot — Major pharmaceutical companies are citing their
As Democrats prepare a massive overhaul of prescription drug policy, major pharmaceutical companies are mounting a lobbying campaign against it, [...]
PhRMA Takes Aim at Medicare Price Negotiation as HHS Digs In
Policies aimed at slowing price growth in the most expensive drug categories could result in slightly fewer drugs coming to [...]
Healthcare CRM Market Worth $17.4 Billion by 2023 – Exclusive Report by MarketsandMarkets™ – Press Release
Pune , India , 2021-Sep-11 — /EPR Network/ — According to the new market research report “Healthcare CRM Market by [...]
As Congress considers drug price reforms, Merck, Lilly and Takeda execs warn of dire consequences
As Congress reconvenes this month to resolve a $3.5 trillion budget package, Democrats are focused on enacting sweeping legislation that [...]
The Art of the Possible Doable
For years, biopharma and healthcare organizations have fantasized about making better use of real-world data. The appeal has long been [...]
PQA-Supported Research Examines Cost Barriers to Medication Access and Adherence
The Pharmacy Quality Alliance (PQA) developed the “ Medication Access Framework for Quality Measurement ” to address the social determinants [...]
How To Diversify Trials: Recruitment Protocols, Other Approaches
How To Diversify Trials: Recruitment Protocols, Other Approaches By Allison Proffitt September 9, 2021 | If you can’t measure it, [...]
What is the Specialty Drug Commercialization Pipeline?
Specialty drugs are high cost pharmaceutical products intended for a small number of patients. The specialty drug commercialization process requires [...]
Recent ISPOR Study Highlights the Use of RWE in Decision-Making
In a recent study published in Value in Health, researchers investigated how real world evidence (RWE) impacted decision-making by the [...]
Biogen CEO Discusses Tumultuous Aduhelm Launch
Biogen CEO Michel Vounatsos recently shared his thoughts regarding the hectic Aduhelm launch at the Morgan Stanley 19th Annual Global [...]
ISPOR Article on Prescription Drug Price Variation in Last Decade
In a recent article published in Value in Health, the authors investigate pharmaceutical drug prices. They note significant variation among payers; [...]
MAPS Webinar Features Authors of Recent MSL Position Statement
The Medical Affairs Professional Society (MAPS) is offering an on-demand webinar featuring insight from the authors of a recently published [...]
Vesto and Oldham Global Collaborate to Offer Financing for High Cost Therapies
Crypto company Vesto and development company Oldham Global have announced a partnership to provide financing for expensive pharmaceuticals. Payers and [...]
Freakonomics, M.D. Podcast on Medical Mysteries Now Available
In the fifth installment of Freakonomics, M.D., Dr. Bapu Jena discusses medical mysteries. He highlights the surprising case of a woman [...]
Harvard Researcher Discusses the Surprising Role of Barbershops in Healthcare
Dr. Bapu Jena highlights the surprising link between barbershops and trust in healthcare. Could barbershops improve health equity? “Bapu Jena [...]
MAPS Podcast on Distinguishing Between Insights and Observations
The Medical Affairs Professional Society (MAPS) is offering a podcast that highlights the differences between insights and observations. Speakers include [...]
Over 15 million U.S. adults under 65 went without medication in 2021 due to high drug costs, study shows
An estimated 15.5 million adults under 65 and 2.3 million seniors were unable to pay for at least one doctor-prescribed [...]
HHS aims to use value-based care payment models to lower drug prices
The Department of Health and Human Services wants to test models that would pay drugs based on their clinical value [...]
HHS Secretary Xavier Becerra Releases Bold Proposal to Lower Prescription Drug Costs
202-690-6343 HHS Secretary Xavier Becerra Releases Bold Proposal to Lower Prescription Drug Costs Today, Health and Human Services (HHS) Secretary [...]
Drug Stocks Drop on White House Plan to Lower Drug Costs
Stocks of pharmaceutical makers slumped on Thursday after the Biden Administration unveiled plans to lower prescription-drug pricing for Americans. The [...]
Healthcare Reform in a Post-Pandemic World
Healthcare Reform in a Post-Pandemic World The industrialized world’s most unequal and inefficient healthcare system underwent a stress test this [...]
US government to tackle Medicare drug payments to try to cut costs
WASHINGTON: President Joe Biden's administration on Thursday (Sep 9) unveiled its promised initiative aimed at cutting drug prices, saying it [...]
Protect American Medical Innovation from Misguided Reform
[Skip to comments. ](#comment) Posted on 09/12/2021 5:11:27 AM PDT by [Kaslin](/~kaslin/) Americans are learning and relearning many lessons from [...]
Biden reveals plan to lower prescription drug costs by directly negotiating with pharma companies
The Biden administration unveiled a plan to lower prescription drug prices for Medicare recipients on Thursday that would include backing [...]